Thrombosis and cancer: 40 years of research

Thrombosis Research

Volumn 129, Issue 3, 2012, Pages 348-352

  Donati, Maria Benedetta ^a   Lorenzet, Roberto ^a  

^a Fondazione di Ricerca e Cura Giovanni Paolo II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RETINOIC ACID; THROMBOPLASTIN; TUMOR EXTRACT; WARFARIN;

ACUTE LEUKEMIA; ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CYTOLOGY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; FIBRIN FORMATION; HEMATOLOGIC MALIGNANCY; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RESEARCH; REVIEW; RISK; SOLID TUMOR; THROMBOSIS; TUMOR CELL; TUMOR GROWTH; VENOUS THROMBOEMBOLISM;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION; FIBRINOLYTIC AGENTS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEOPLASMS; RISK FACTORS; THROMBOPLASTIN; THROMBOSIS;

EID: 84857788785     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.12.022     Document Type: Review

References (72)

1. A. Trousseau Phlegmasia Alba Dolens 2nd ed. Clinique Médicale de l'Hotel Dieu de Paris vol. 3 1865 JB Baillère Paris 659-12
2. T. Billroth Lectures on surgical pathology and therapeutics:a handbook for students and practitioners 8th ed. 1878 The New Sydenham Society London 1877 1878
3. E.E. Cliffton, and C.E. Grossi Fibrinolytic activity of human tumors as measured by the fibrin-plate method Cancer 8 1955 1146 1154
4. C.E. Grossi, D. Agostino, and E.E. Cliffton The effect of human fibrinolysin on pulmonary metastases of Walker 256 carcinoma Cancer Res 20 1960 605 608
5. D. Agostino, C.E. Grossi, and E.E. Cliffton Effect of heparin on circulating Walker carcinosarcoma 256 cells J Natl Cancer Inst 5 1961 463 473
6. E.E. Cliffton, and D. Agostino Factors affecting the development of metastatic cancer. Effect of alterations in clotting mechanism Cancer 15 1962 276 283
7. M.B. Donati Thrombosis and cancer; a personal view Thromb Haemost 98 2007 126 128
8. E. Dolfini, B. Azzarone, D. Pedulla, E. Ottaviano, G. de Gaetano, M.B. Donati, and L. Morasca Characterization of human fibroblasts from cancer patients: loss of fibrin clot retractile activity after 'in vitro' spontaneous transformation Eur J Cancer 12 1976 823 825
9. M.B. Donati, E. Dolfini, L. Morasca, and G. de Gaetano Fibrin clot retraction by a rat rhabdomyosarcoma cell line Thromb Res 8 1976 707 711
10. L. Curatolo, M. Colucci, A.L. Cambini, A. Poggi, L. Morasca, M.B. Donati, and N. Semeraro Evidence that cells from experimental tumours can activate coagulation factor X Br J Cancer 40 1979 228 233 (Pubitemid 9250474)
11. A. Poggi, N. Polentarutti, M. Benedetta Donati, G. de Gaetano, and S. Garattini Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor Cancer Res 37 1977 272 277 (Pubitemid 8008647)
12. J. Chmielewska, A. Poggi, L. Mussoni, M.B. Donati, and S. Garattini Blood coagulation changes in JW sarcoma, a new metastasizing tumour in mice Eur J Cancer 16 1980 1399 1407 (Pubitemid 11226634)
13. L. Mussoni, A. Poggi, G. de Gaetano, and M.B. Donati Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice Br J Cancer 37 1978 126 129 (Pubitemid 8261455)
14. A. Poggi, L. Mussoni, L. Kornblihtt, E. Ballabio, G. de Gaetano, and M.B. Donati Warfarin enantiomers, anticoagulation, and experimental tumor metastasis Lancet 1 1978 163 164 (Pubitemid 8264262)
15. J. Chmielewska, A. Poggi, P. Janik, Z.S. Latallo, and M.B. Donati Effect of defibrination with batroxobin on growth and metastasis of JW sarcoma in mice Eur J Cancer 16 1980 919 923 (Pubitemid 10090028)
16. S.G. Gordon, J.J. Franks, and B. Lewis Cancer procoagulant A: a factor X-activating procoagulant from malignant tissue Thromb Res 6 1975 127 137
17. M. Colucci, F. Delaini, Vitti G. de Bellis, D. Locati, A. Poggi, N. Semeraro, and M.B. Donati Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency Biochem Pharmacol 32 1983 1689 1691 (Pubitemid 13060036)
18. R. Lorenzet, B. Bottazzi, D. Locati, M. Colucci, A. Mantovani, N. Semeraro, and M.B. Donati Failure of warfarin to affect the tissue factor activity and the metastatic potential of murine fibrosarcoma cells Eur J Cancer Clin Oncol 21 1985 263 265 (Pubitemid 15169702)
19. M.B. Donati, C. Gambacorti-Passerini, B. Casali, A. Falanga, P. Vannotti, G. Fossati, N. Semeraro, and S.G. Gordon Cancer procoagulant in human tumor cells: evidence from melanoma patients Cancer Res 46 1986 6471 6474 (Pubitemid 17221803)
20. G. Grignani, A. Falanga, L. Pacchiarini, M.G. Alessio, M. Zucchella, P. Fratino, and M.B. Donati Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties Int J Cancer 42 1988 554 557 (Pubitemid 18264066)
21. A. Falanga, M.G. Alessio, M.B. Donati, and T. Barbui A new procoagulant in acute leukemia Blood 71 1988 870 875
22. M.B. Donati, A. Falanga, R. Consonni, M.G. Alessio, R. Bassan, M. Buelli, L. Borin, L. Catani, E. Pogliani, and L. Gugliotta Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity Thromb Haemost 64 1990 11 16 (Pubitemid 20301842)
23. A. Falanga, L. Iacoviello, V. Evangelista, D. Belotti, R. Consonni, A. D'Orazio, L. Robba, M.B. Donati, and T. Barbui Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid Blood 86 1995 1072 1081
24. A. Falanga, and S.G. Gordon Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue Biochemistry 24 1985 5558 5567 (Pubitemid 16228838)
25. T. Barbui, G. Finazzi, and A. Falanga The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukaemia Blood 91 1998 3093 3102 (Pubitemid 28193856)
26. M.C. Roncaglioni, A.P. Dalessandro, B. Casali, C. Vermeer, and M.B. Donati Gamma-glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant Haemostasis 16 1986 295 299 (Pubitemid 16012067)
27. C. Rossi, S. Hess, R.W. Eckl, A. di Lena, A. Bruno, O. Thomas, and A. Poggi Effect of MCM09, an active site-directed inhibitor of factor Xa, on B16-BL6 melanoma lung colonies in mice J Thromb Haemost 4 2006 608 613
28. R. Lorenzet, G. Peri, D. Locati, P. Allavena, M. Colucci, N. Semeraro, A. Mantovani, and M.B. Donati Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues Blood 62 1983 271 273 (Pubitemid 13036072)
29. A. Rambaldi, G. Alessio, B. Casali, C.G. Passerini, M.B. Donati, A. Mantovani, and N. Semeraro Induction of monocyte-macrophage procoagulant activity by transformed cell lines J Immunol 136 1986 3848 3855 (Pubitemid 16122088)
30. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
31. M.N. Levine, M. Gent, J. Hirsh, A. Arnold, M.D. Goodyear, W. Hryniuk, and S. De Pauw The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N Engl J Med 318 1988 404 407 (Pubitemid 18044179)
32. M. Levine, J. Hirsh, M. Gent, A. Arnold, D. Warr, A. Falanga, M. Samosh, V. Bramwell, K.I. Pritchard, and D. Stewart Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer Lancet 343 1994 886 889 (Pubitemid 24113632)
33. T. Barbui, and A. Falanga Thalidomide and thrombosis in multiple myeloma J Thromb Haemost 3 2003 421 422
34. P. Prandoni, A.W. Lensing, H.R. Büller, A. Cogo, M.H. Prins, A.M. Cattelan, S. Cuppini, F. Noventa, and J.W. ten Cate Deep-vein thrombosis and the incidence of subsequent symptomatic cancer N Engl J Med 327 1992 1128 1133
35. P. Prandoni, A. Falanga, and A. Piccioli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410 (Pubitemid 40753746)
36. M. Carrier, G. Le Gal, P.S. Wells, D. Fergusson, T. Ramsay, and M.A. Rodger Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Int Med 149 2008 323 333
37. M.B. Donati, and A. Poggi Malignancy and haemostasis Br J Haematol 44 1980 173 182
38. A. Poggi, M.B. Donati, and S. Garattini Fibrin and cancer cell growth: problems in the evaluation of experimental models Malignancy and the hemostatic system 1981 Raven Press New York 89 101
39. M.R. Bani, A. Falanga, M.G. Alessio, E. Radice, R. Consonni, R. Giavazzi, and M.B. Donati Blood coagulation changes in nude mice bearing human colon carcinomas Int J Cancer 50 1992 75 79
40. A. Falanga The effect of anticoagulant drugs on cancer J Thromb Haemost 2 2004 1263 1265 (Pubitemid 40186119)
41. A.Y. Lee, M.N. Levine, R.I. Baker, C. Bowden, A.K. Kakkar, M. Prins, F.R. Rickles, J.A. Julian, S. Haley, M.J. Kovacs, and M. Gent Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146 153 (Pubitemid 36818784)
42. M. Altinbas, H.S. Coskun, O. Er, M. Ozkan, B. Eser, A. Unal, M. Cetin, and S. Soyuer A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer J Thromb Haemost 2 2004 1266 1271 (Pubitemid 40186120)
43. A.K. Kakkar, M.N. Levine, Z. Kadziola, N.R. Lemoine, V. Low, H.K. Patel, G. Rustin, M. Thomas, M. Quigley, and R.C. Williamson Low molecular weight heparin therapy with dalteparin and survival in advanced cancer: the framing advanced malignancy outcome study (FAMOUS) J Clin Oncol 22 2004 1944 1948 (Pubitemid 41095187)
44. C.P. Klerk, S.M. Smorenburg, H.M. Otten, A.W. Lensing, M.H. Prins, F. Piovella, P. Prandoni, M.M. Bos, D.J. Richel, G. van Tienhoven, and H.R. Büller The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2005 2130 2135 (Pubitemid 46218704)
45. A.Y. Lee, F.R. Rickles, J.A. Julian, M. Gent, R.I. Baker, C. Bowden, A.K. Kakkar, M. Prins, and M.N. Levine Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism J Clin Oncol 23 2005 2123 2129 (Pubitemid 46218703)
46. N. Maugeri, G. de Gaetano, M. Barbanti, M.B. Donati, and C. Cerletti Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparins Haematologica 90 2005 815 821
47. N. Maugeri, G. Di Fabio, M. Barbanti, G. de Gaetano, M.B. Donati, and C. Cerletti Parnaparin, a low molecular weight heparin, prevents P-selectin- dependent formation of platelet- leukocyte aggregates in human whole blood Thromb Haemost 97 2007 965 973
48. D.M. Monroe, and N.S. Key The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking J Thromb Haemost 5 2007 1097 1105 (Pubitemid 46902106)
49. N. Semeraro, A. Biondi, R. Lorenzet, D. Locati, A. Mantovani, and M.B. Donati Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites Immunology 50 1983 529 535 (Pubitemid 14246895)
50. N. Maugeri, M. Brambilla, M. Camera, A. Carbone, E. Tremoli, M.B. Donati, G. de Gaetano, and C. Cerletti Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation J Thromb Haemost 2006 41323 41330
51. M. Camera, M. Frigerio, V. Toschi, M. Brambilla, F. Rossi, D.C. Cottell, P. Maderna, A. Parolari, R. Bonzi, O. De Vincenti, and E. Tremoli Platelet activation inducescell-surface immunoreactive tissue factor expression, which is modulateddifferently by antiplatelet drugs Arterioscler Thromb Vasc Biol 23 2003 1690 1696 (Pubitemid 37108218)
52. P.L. Giesen, U. Rauch, B. Bohrmann, D. Kling, M. Roqué, J.T. Fallon, J.J. Badimon, J. Himber, M.A. Riederer, and Y. Nemerson Blood-borne tissue factor: Another view of thrombosis Proc Natl Acad Sci USA 96 1999 2311 2315 (Pubitemid 29117911)
53. R.S. Kasthuri, M.B. Taubman, and N. Mackman Role of tissue factor in cancer J Clin Oncol 27 2009 4834 4838
54. H.F. Dvorak, L. Van DeWater, A.M. Bitzer, A.M. Dvorak, D. Anderson, V.S. Harvey, R. Bach, G.L. Davis, W. DeWolf, and A.C. Carvalho Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells Cancer Res 43 1983 4434 4442 (Pubitemid 13041884)
55. M.E. Tesselaar, F.P. Romijn, I.K. Van Der Linden, F.A. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 2007 520 527 (Pubitemid 46680685)
56. N. Semeraro, and M. Colucci Tissue factor in health and disease Thromb Haemost 78 1997 759 764 (Pubitemid 27289340)
57. J. Contrino, G. Hair, D.L. Kreutzer, and F.R. Rickles In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease Nat Med 2 1996 209 215 (Pubitemid 26054985)
58. M.B. Donati, and R. Lorenzet The role of blood clotting in tumor metastasis: a case for tissue factor G. Lugassy, A. Falanga, A.K. Kakkar, F.R. Rickles, Thrombosis and Cancer 2004 Martin Dunitz Limited London 47 58
59. T.A. Hembrough, G.M. Swartz, A. Papathanassiu, G.P. Vlasuk, W.E. Rote, S.J. Green, and V.S. Pribluda Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism Cancer Res 63 2003 2997 3000 (Pubitemid 36667175)
60. H.H. Versteeg, F. Schaffner, M. Kerver, H.H. Petersen, J. Ahamed, B. Felding-Habermann, Y. Takada, B.M. Mueller, and W. Ruf Inhibition of tissue factor signaling suppresses tumor growth Blood 111 2008 190 199
61. J.L. Yu, L. May, V. Lhotak, S. Shahrzad, S. Shirasawa, J.I. Weitz, B.L. Coomber, N. Mackman, and J.W. Rak Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis Blood 105 2005 1734 1741 (Pubitemid 40223697)
62. M.E. Bromberg, W.H. Konigsberg, J.F. Madison, A. Pawashe, and A. Garen Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation Proc Natl Acad Sci USA 92 1995 8205 8209
63. M.E. Bromberg, R. Sundaram, R.J. Homer, A. Garen, and W.H. Konigsberg Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule Thromb Haemost 82 1999 88 92 (Pubitemid 29368778)
64. B.M. Mueller, and W. Ruf Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis J Clin Invest 101 1998 1372 1378 (Pubitemid 28166834)
65. M.B. Donati, and R. Lorenzet Overview on tumor angiogenesis F.S. Markland, S. Swenson, R. Minea, Tumor Angiogenesis. From Molecular Mechanisms to Targeted Therapy 2010 Wiley-Blackwell Weinheim 3 14
66. A. Amirkhosravi, T. Meyer, J.Y. Chang, M. Amaya, F. Siddiqui, H. Desai, and J.L. Francis Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma Thromb Haemost 87 2002 930 936 (Pubitemid 34624872)
67. P. Carmeliet, N. Mackman, L. Moons, T. Luther, P. Gressens, I. Van Vlaenderen, H. Demunck, M. Kasper, G. Breier, P. Evrard, M. Müller, W. Risau, T. Edgington, and D. Collen Role of tissue factor in embryonic blood vessel development Nature 383 1996 73 75 (Pubitemid 26296462)
68. W. Ruf, J. Disse, T.C. Carneiro-Lobo, N. Yokota, and F. Schaffner Tissue factor and cell signalling in cancer progression and thrombosis J Thromb Haemost 9 Suppl. 1 2011 306 315
69. M.B. Donati, A. Falanga, and R. Lorenzet Cancer and thrombosis: a two-way interaction J. Arnout, G. de Gaetano, M. Hoylaerts, K. Peerlinck, C. Van Geet, R. Verhaeghe, Thrombosis: Fundamental and Clinical Aspects 2003 Leuven University Press 417 431
70. Y. Zhang, Y. Deng, T. Luther, M. Muller, R. Ziegler, R. Waldherr, D.M. Stern, and P.P. Nawroth Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice J Clin Invest 94 1994 1320 1327 (Pubitemid 24286478)
71. E. Napoleone, F. Zurlo, M.C. Latella, C. Amore, A. Di Santo, L. Iacoviello, M.B. Donati, and R. Lorenzet Paclitaxel downregulates tissue factor in cancer and host tumor-associated cells Eur J Cancer 45 2009 470 477
72. E. Napoleone, A. Cutrone, D. Cugino, C. Amore, A. Di Santo, L. Iacoviello, G. de Gaetano, M.B. Donati, and R. Lorenzet Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells Thromb Res 2011 10.1016/j.thromres.2011.11.047